A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

Amid a historically unprecedented barrage of executive orders, the key question is: Does the president have the power to ...

Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an inve ...

A visit to resistance-held Karen State reveals the impact of four years of war, and the determination of ordinary citizens to ...

The ECS Liva Z7 Plus provides the performance of a desktop-replacement laptop and exceptional connectivity in a compact ...

Nor, really, is the gimmicky touchpad on Acer's new Swift 16 AI ($1,199.99 as tested), which lights up when using AI apps.

Lenovo's LOQ Gaming Tower is almost petite enough to be a small-form-factor system, measuring 14.8 by 6.7 by 11 inches. It ...

The challenges of translating neuroprotective interventions with promising efficacy in animal studies into effective treatments for patients with stroke are well documented, with issues including ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Increased relative risk of stroke and myocardial infarction, but absolute risk is low Approximately 80% of women worldwide have used hormonal contraception at some point in their lives.1 This high ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...